Why the study?
Anti-epileptic drugs are associated with an increased risk of sudden cardiac death, prompting investigation into whether specific agents reduce the cardiac Nav1.5 current.
Do anti-epileptic drugs (gabapentin, lamotrigine, levetiracetam, pregabalin, valproic acid) reduce the Nav1.5 current in cardiac cells?
Do anti-epileptic drugs (gabapentin, lamotrigine, levetiracetam, pregabalin, valproic acid) reduce the Nav1.5 current in cardiac cells?
Lamotrigine and valproic acid inhibit cardiac Nav1.5 currents and reduce action potential upstroke velocity, providing a potential mechanism for the increased risk of sudden cardiac death associated with these drugs.
Answers are grounded in this paper and cite their sources.
May heighten arrhythmia risk with lamotrigine or valproic acid; leaves open clinical impact of observed Nav1.5 effects.
Anti-epileptic drugs (AEDs) are associated with increased risk of sudden cardiac death. To establish whether gabapentin, lamotrigine, levetiracetam, pregabalin, and valproic acid reduce the Nav1.5 current, we conducted whole-cell patch-clamp studies to study the effects of the five AEDs on currents of human cardiac Nav1.5 channels stably expressed in HEK293 cells, and on action potential (AP) properties of freshly isolated rabbit ventricular cardiomyocytes. Lamotrigine and valproic acid exhibited inhibitory effects on the Nav1.5 current in a concentration-dependent manner with an IC50 of 142 ± 36 and 2022 ± 25 µM for lamotrigine and valproic acid, respectively. In addition, these drugs caused a hyperpolarizing shift of steady-state inactivation and a delay in recovery from inactivation. The changes on the Nav1.5 properties were reflected by a reduction in AP upstroke velocity (43.0 ± 6.8% (lamotrigine) and 23.7 ± 10.6% (valproic acid) at 1 Hz) and AP amplitude; in contrast, AP duration was not changed. Gabapentin, levetiracetam, and pregabalin had no effect on the Nav1.5 current. Lamotrigine and valproic acid reduce the Nav1.5 current density and affect its gating properties, resulting in a decrease of the AP upstroke velocity. Gabapentin, levetiracetam, and pregabalin have no effects on the Nav1.5 current.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: